DiaMedica Therapeutics Inc
DMAC
Get informed when a big investor buys or sells
+ FollowMarket Cap$322.76M
Close$
$0.33
94.2% downside
Current Fair Value
94.2% downsideOvervalued by 94.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $322.76 Million |
|---|---|
| Enterprise Value | $318.10 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.7 |
| Beta | 0.99 |
| Outstanding Shares | 53,793,490 |
Return
| Return on Equity | -74.31% |
|---|---|
| Return on Assets | -66.13% |
| Return on Invested Capital | -54.80% |
Valuation & Multiples
| P/E Ratio | -9.18 |
|---|---|
| PEG | -30.3 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -12.26 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$13.50 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$13.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7432▼ 10.51% |
|---|---|
| Total Calls | 22,200▼ 19.86% |
| Total Puts | 16,500▼ 29.79% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 24.90%▲ 0.61% |
|---|---|
| Total Invested | $79.16M▼ 17.53% |
| Investors Holding | 101▲ 6.00% |
ESG Score
No data